35 studies found for:    "Ocular melanoma"
Show Display Options
Rank Status Study
1 Unknown  Study of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Gemcitabine;   Drug: Treosulfan
2 Recruiting STA-9090(Ganetespib) in Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Intervention: Drug: STA-9090
3 Recruiting Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Sorafenib;   Device: Radioembolization with SIR-Spheres® (Yttrium Microspheres)
4 Recruiting Adoptive T Cell Therapy for Metastatic Ocular Melanoma
Conditions: Metastatic Ocular Melanoma;   Metastatic Uveal Melanoma
Interventions: Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Tumor Infiltrating Lymphocytes
5 Withdrawn Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
Condition: Ocular Melanoma
Interventions: Drug: Pegylated Interfon Alpha 2B;   Drug: Placebo
6 Unknown  Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma;   Choroidal Melanoma;   Uveal Melanoma
Intervention:
7 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
8 Completed THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
Condition: Ocular Melanoma
Intervention: Drug: Ipilimumab
9 Recruiting Definity for Ultrasound of Intraocular Tumors
Condition: Ocular Melanoma
Intervention: Device: Microbubble contrast agent
10 Unknown  Cytogenetic Study of Ocular Melanoma
Condition: Choroidal Melanoma
Intervention:
11 Completed
Has Results
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Revlimid
12 Completed A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
Condition: Melanoma
Intervention: Procedure: Laparotomy
13 No longer available Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Conditions: Metastatic Liver Cancer;   Ocular Melanoma;   Cutaneous Melanoma
Interventions: Drug: Melphalan;   Device: Percutaneous Hepatic Perfusion
14 Terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Imatinib
15 Unknown  Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Condition: Intraocular Melanoma
Interventions: Drug: cisplatin;   Drug: sunitinib malate;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
16 Completed Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Intervention: Biological: recombinant interferon beta
17 Completed Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: pyrazoloacridine
18 Completed Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Extraocular Extension Melanoma;   Recurrent Intraocular Melanoma
Interventions: Drug: gp100 antigen;   Drug: interleukin-2;   Drug: MART-1 antigen;   Drug: Montanide ISA-51
19 Terminated Vaccine Therapy in Treating Patients With Melanoma of the Eye
Condition: Intraocular Melanoma
Interventions: Biological: MART-1 antigen;   Biological: NA17-A antigen;   Biological: gp100 antigen;   Biological: tyrosinase peptide
20 Recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Metastatic Intraocular Melanoma;   Recurrent Intraocular Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIC Intraocular Melanoma;   Stage IV Intraocular Melanoma
Interventions: Drug: cabozantinib-s-malate;   Drug: temozolomide;   Drug: dacarbazine;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
Indicates status has not been verified in more than two years